Notes to SEFA
Title: Note 3: CONTINGENCIES
Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of the National Foundation for the Centers for Disease Control and Prevention, Inc. (the Foundation) and is presented on the accrual basis of accounting.
The information reported on this Schedule is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this Schedule may differ from amounts presented in, or used in the preparation of, the basic financial statements.
The purpose of the Schedule is to present a summary of those activities of the Foundation for the year ended June 30, 2023, which have been financed by the United States Government.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, Audit Requirements for
Federal Awards, wherein certain types of expenditures are not allowable or are limited as to the amount of the reimbursement. Pass‐through identifying numbers are presented where available.
De Minimis Rate Used: N
Rate Explanation: The Foundation has elected not to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance.
Grant monies received and disbursed are for specific purposes and are subject to review by the grantor agencies. Such audits may result in certain requests for reimbursement not being paid due to disallowed expenditures. Management does not believe that such disallowance, if any, would have a material effect on its financial position. As of June 30, 2023, there were no material questioned or disallowed costs as a result of the grant audits in process or completed.
Title: Note 5: OTHER INFORMATION
Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of the National Foundation for the Centers for Disease Control and Prevention, Inc. (the Foundation) and is presented on the accrual basis of accounting.
The information reported on this Schedule is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this Schedule may differ from amounts presented in, or used in the preparation of, the basic financial statements.
The purpose of the Schedule is to present a summary of those activities of the Foundation for the year ended June 30, 2023, which have been financed by the United States Government.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, Audit Requirements for
Federal Awards, wherein certain types of expenditures are not allowable or are limited as to the amount of the reimbursement. Pass‐through identifying numbers are presented where available.
De Minimis Rate Used: N
Rate Explanation: The Foundation has elected not to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance.
There were no subsidized insurance paid by the federal government, noncash assistance nor loan balances or guarantee programs for the year ended June 30, 2023.